SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,605 | +65.1% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,450 | +5.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $8,960 | +40.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,370 | -23.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $8,370 | -7.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $9,050 | -16.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $10,770 | +12.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $9,540 | -16.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $11,480 | -32.3% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $16,950 | +19.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $14,200 | -25.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $19,000 | +15.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,400 | +9.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $15,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |